Crocin Combined with Cisplatin Regulates Proliferation, Apoptosis, and EMT of Gastric Cancer Cells via the FGFR3/MAPK/ERK Pathway In vitro and In vivo

被引:0
作者
Li, Yan [1 ]
Guo, Qi-Jing [1 ,2 ]
Chen, Rong [1 ]
Zhao, Linglin [2 ]
Cui, Xianshu [1 ]
Deng, Yingfang [1 ]
Luo, Yu-Shuang [1 ,2 ]
机构
[1] Qinghai Univ, Affiliated Hosp, Dept Oncol, Xining, Qinghai, Peoples R China
[2] Qinghai Univ, High Altitude Med Res Ctr, Minist Educ, Key Lab High Altitude Med,Qinghai Utah Joint Res K, Xining 810001, Qinghai, Peoples R China
关键词
Crocin; cisplatin; fibroblast growth factor receptor 3; gastric cancer; MAPK/ERK; signaling pathway; GROWTH; CARCINOMA;
D O I
10.2174/1568009624666230915111239
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Cisplatin (DDP)-based chemotherapy remains the main therapeutic strategy for human gastric cancer (GC). Combination therapy with Chinese medicine monomers and DDP has been investigated as a means to enhance the anti-tumor effect of DDP while reducing toxicity. Material and Methods: Previous studies have shown that crocin combined with DDP can inhibit the apoptosis of BG-823 GC cells. However, the mechanism of this combination therapy in inhibiting GC is not fully unclear. In this study, we measured the IC50 values of crocin combined with DDP in AGS cells and assessed its effect on cell proliferation using an MTT assay. Furthermore, we assessed apoptosis, cell migration, and EMT-related protein levels by using flow cytometry, scratch assay, and Western blotting, respectively. Our results showed that crocin combined with DDP inhibited the proliferation, induced apoptosis, and inhibited invasion and EMT. Next, we performed RNA sequence and KEGG enrichment analysis on GC cells treated with Crocin+DDP. Results: The results showed that the most significant factor down-regulated by this combination therapy was Fibroblast growth factor receptor 3 (FGFR3) expression and that a differential gene was enriched in the MAPK/ERK pathway. We further constructed an FGFR3 OE transfection plasmid to overexpress FGFR3 and evaluate its effects on proliferation, apoptosis, migration, EMT, and MAPK/ERK pathway proteins in GC cells. We also conducted subcutaneous tumorigenesis experiments in nude mice to evaluate the effects of crocin and DDP on the progression of GC xenografts in vivo. Finally, we performed a rescue experiment using the MAPK/ERK pathway inhibitor PD184352. Conclusion: Our results showed that up-regulation of FGFR3 reversed the inhibitory effect of crocin+DDP on the MAPK/ERK signaling pathway. Still, this effect could be counteracted by PD184352, which simultaneously regulated the proliferation, apoptosis, and EMT of AGS cells. In conclusion, crocin, combined with DDP, inhibits proliferation, apoptosis, and EMT of GC through the FRFR3/MAPK/ERK pathway.
引用
收藏
页码:835 / 845
页数:11
相关论文
共 31 条
  • [1] Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2)
    Aviles, RJ
    Annex, BH
    Lederman, RJ
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (04) : 637 - 646
  • [2] Advances and challenges in targeting FGFR signalling in cancer
    Babina, Irina S.
    Turner, Nicholas C.
    [J]. NATURE REVIEWS CANCER, 2017, 17 (05) : 318 - 332
  • [3] Fibroblast growth factor receptor 3-mediated reactivation of ERK signaling promotes head and neck squamous cancer cell insensitivity to MEK inhibition
    Ban, Myung Jin
    Byeon, Hyung Kwon
    Yang, Yeon Ju
    An, Sojung
    Kim, Jae Wook
    Kim, Ji-Hoon
    Kim, Da Hee
    Yang, Jaemoon
    Kee, Hyunjung
    Koh, Yoon Woo
    [J]. CANCER SCIENCE, 2018, 109 (12): : 3816 - 3825
  • [4] Antiangiogenic effect of crocin on breast cancer cell MDA-MB-231
    Chen, Shuang-Shuang
    Gu, Yuan
    Lu, Fang
    Qian, Dan-Ping
    Dong, Ting-Ting
    Ding, Zhong-Hai
    Zhao, Shuang
    Yu, Zheng-Hong
    [J]. JOURNAL OF THORACIC DISEASE, 2019, 11 (11) : 4464 - 4473
  • [5] ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer
    di Martino, Erica
    Alder, Olivia
    Hurst, Carolyn D.
    Knowles, Margaret A.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [6] miRNA-381-3p Functions as a Tumor Suppressor to Inhibit Gastric Cancer by Targeting Fibroblast Growth Factor Receptor-2
    Gao, Xiang
    Liu, Huiqi
    Wu, Qiong
    Wang, Rong
    Huang, Mingyu
    Ma, Qiang
    Liu, Yongnian
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2023, 38 (06) : 396 - 404
  • [7] The second wave in kinase cancer drugs
    Garber, K
    [J]. NATURE BIOTECHNOLOGY, 2006, 24 (02) : 127 - 130
  • [8] Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation
    Hart, KC
    Robertson, SC
    Donoghue, DJ
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (04) : 931 - 942
  • [9] Integrated analysis of whole genome and transcriptome sequencing in a young patient with gastric cancer provides insights for precision therapy
    Hu, Kongwang
    Yu, Weiqiang
    Ajayi, Olugbenga Emmanuel
    Li, Longlong
    Huang, Zhiguo
    Rong, Qiqi
    Wang, Shuaili
    Wu, Qing-Fa
    [J]. ONCOLOGY LETTERS, 2020, 20 (04)
  • [10] FGFR3 Destabilizes PD-L1 via NEDD4 to Control T-cell- Mediated Bladder Cancer Immune Surveillance
    Jing, Weiqiang
    Wang, Ganyu
    Cui, Zhiwei
    Xiong, Gaozhong
    Jiang, Xin
    Li, Yue
    Li, Wushan
    Han, Bo
    Chen, Shouzhen
    Shi, Benkang
    [J]. CANCER RESEARCH, 2022, 82 (01) : 114 - 129